1
|
Lobato-Berezo A, Pujol RM. Oral Condyloma Lata in Secondary Syphilis With Kissing Distribution. Actas Dermosifiliogr 2024; 115:T183. [PMID: 38048952 DOI: 10.1016/j.ad.2023.11.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2022] [Accepted: 09/04/2022] [Indexed: 12/06/2023] Open
Affiliation(s)
- A Lobato-Berezo
- Department of Dermatology, Hospital del Mar-Parc de Salut Mar, Barcelona, Spain.
| | - R M Pujol
- Department of Dermatology, Hospital del Mar-Parc de Salut Mar, Barcelona, Spain
| |
Collapse
|
2
|
Lobato-Berezo A, López-Trujillo E, Pujol RM. Tufted Hair Follicles Associated With Lipedematous Alopecia: Magnetic Resonance Imaging and Ultrasounds Assessment. Actas Dermosifiliogr 2024; 115:T198-T199. [PMID: 37952838 DOI: 10.1016/j.ad.2023.11.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2022] [Accepted: 07/07/2022] [Indexed: 11/14/2023] Open
Affiliation(s)
- A Lobato-Berezo
- Department of Dermatology, Hospital del Mar-Parc de Salut Mar, Barcelona, España.
| | - E López-Trujillo
- Department of Dermatology, Hospital del Mar-Parc de Salut Mar, Barcelona, España
| | - R M Pujol
- Department of Dermatology, Hospital del Mar-Parc de Salut Mar, Barcelona, España
| |
Collapse
|
3
|
Lobato-Berezo A, Pujol RM. Oral Condyloma Lata in Secondary Syphilis With Kissing Distribution. Actas Dermosifiliogr 2024; 115:183. [PMID: 37661076 DOI: 10.1016/j.ad.2022.09.030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2022] [Revised: 09/02/2022] [Accepted: 09/04/2022] [Indexed: 09/05/2023] Open
Affiliation(s)
- A Lobato-Berezo
- Department of Dermatology, Hospital del Mar-Parc de Salut Mar, Barcelona, Spain.
| | - R M Pujol
- Department of Dermatology, Hospital del Mar-Parc de Salut Mar, Barcelona, Spain
| |
Collapse
|
4
|
Lobato-Berezo A, López-Trujillo E, Pujol RM. Tufted Hair Follicles Associated With Lipedematous Alopecia: Magnetic Resonance Imaging and Ultrasounds Assessment. Actas Dermosifiliogr 2024; 115:198-199. [PMID: 37321547 DOI: 10.1016/j.ad.2022.07.040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2022] [Revised: 07/04/2022] [Accepted: 07/07/2022] [Indexed: 06/17/2023] Open
Affiliation(s)
- A Lobato-Berezo
- Department of Dermatology, Hospital del Mar-Parc de Salut Mar, Barcelona, Spain.
| | - E López-Trujillo
- Department of Dermatology, Hospital del Mar-Parc de Salut Mar, Barcelona, Spain
| | - R M Pujol
- Department of Dermatology, Hospital del Mar-Parc de Salut Mar, Barcelona, Spain
| |
Collapse
|
5
|
Ciudad A, Rivera M, Pujol RM, Martín-Ezquerra G. Variability of Mucocutaneous Signs Within the Spectrum of Reactive Arthritis Syndrome. Actas Dermosifiliogr 2023:S0001-7310(23)01005-0. [PMID: 38159840 DOI: 10.1016/j.ad.2023.09.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/16/2023] [Revised: 09/04/2023] [Accepted: 09/19/2023] [Indexed: 01/03/2024] Open
Affiliation(s)
- A Ciudad
- Servicio de Dermatología, Hospital del Mar, Barcelona, España.
| | - M Rivera
- Servicio de Dermatología, Hospital del Mar, Barcelona, España
| | - R M Pujol
- Servicio de Dermatología, Hospital del Mar, Barcelona, España
| | | |
Collapse
|
6
|
Lobato-Berezo A, Fernández Figueras MT, Pujol RM. Auricular Pseudocysts After Prolonged Protective Mask Wearing for SARS-CoV-2. Actas Dermosifiliogr 2023; 114:T738-T739. [PMID: 37348832 PMCID: PMC10281039 DOI: 10.1016/j.ad.2022.01.060] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2021] [Accepted: 01/30/2022] [Indexed: 06/24/2023] Open
Affiliation(s)
- A Lobato-Berezo
- Departamento de Dermatología, Hospital del Mar-Parc de Salut Mar, Barcelona, España.
| | - M T Fernández Figueras
- Departamento de Patología, Hospital Universitari General de Catalunya, Sant Cugat del Vallès, Barcelona, España
| | - R M Pujol
- Departamento de Dermatología, Hospital del Mar-Parc de Salut Mar, Barcelona, España
| |
Collapse
|
7
|
Escolà H, Figueras-Nart I, Bonfill-Orti M, Coll Puigserver N, Martin-Santiago A, Rodríguez Serna M, Sánchez Hernández MC, Sanz-Cabanillas JL, Taberner R, Zaragoza-Ninet V, Pujol RM, Curto-Barredo L. Dupilumab for atopic dermatitis during pregnancy and breastfeeding: Clinical experience in 13 patients. J Eur Acad Dermatol Venereol 2023; 37:e1156-e1160. [PMID: 37143399 DOI: 10.1111/jdv.19165] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2023] [Accepted: 04/26/2023] [Indexed: 05/06/2023]
Affiliation(s)
- H Escolà
- Department of Dermatology, Hospital del Mar, Barcelona, Spain
| | - I Figueras-Nart
- Department of Dermatology, Hospital Universitari Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain
| | - M Bonfill-Orti
- Department of Dermatology, Hospital Universitari Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain
| | | | - A Martin-Santiago
- Department of Dermatology, Hospital Universitario Son Espases, Palma, Spain
| | - M Rodríguez Serna
- Department of Dermatology, Hospital Universitari i Politècnic La Fe, Valencia, Spain
| | | | - J L Sanz-Cabanillas
- Department of Dermatology, Hospital Universitario Reina Sofía, Cordoba, Spain
| | - R Taberner
- Department of Dermatology, Hospital Son Llatzer, Palma de Mallorca, Spain
| | - V Zaragoza-Ninet
- Department of Dermatology, Hospital General Universitari de Valencia, Valencia, Spain
| | - R M Pujol
- Department of Dermatology, Hospital del Mar, Barcelona, Spain
| | - L Curto-Barredo
- Department of Dermatology, Hospital del Mar, Barcelona, Spain
| |
Collapse
|
8
|
Escolà H, Segura Tigell S, Pujol RM. Diffuse Firm Swelling of the Right Areola. Actas Dermosifiliogr 2023:S0001-7310(23)00611-7. [PMID: 37482294 DOI: 10.1016/j.ad.2023.01.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2022] [Revised: 01/17/2023] [Accepted: 01/25/2023] [Indexed: 07/25/2023] Open
Affiliation(s)
- H Escolà
- Departamento de Dermatología, Hospital del Mar, Parc de Salut Mar, Universitat Autònoma de Barcelona, Barcelona, España.
| | - S Segura Tigell
- Departamento de Dermatología, Hospital del Mar, Parc de Salut Mar, Universitat Autònoma de Barcelona, Barcelona, España
| | - R M Pujol
- Departamento de Dermatología, Hospital del Mar, Parc de Salut Mar, Universitat Autònoma de Barcelona, Barcelona, España
| |
Collapse
|
9
|
Falkenhain-López D, Muniesa C, Estrach MT, Morillo-Andújar M, Peñate Y, Acebo E, Pujol RM, García-Muret MP, Machan S, Medina S, Botella-Estrada R, Fernández de Misa R, Blanes M, Flórez A, Pérez-Paredes G, Izu R, Yanguas I, Silva-Díaz E, Pérez-Ferriols A, Prieto-Torres L, Zayas A, Parera-Amer ME, Pérez A, Aspe L, Román C, Sánchez-Caminero MP, Bassas-Vila J, Domínguez-Auñón JD, Calzado L, Navedo M, Ortiz-Prieto A, Servitje O, Polo-Rodríguez I, Torres I, Hernández-Hernández MN, Mitxelena-Eceiza J, García-Vázquez A, García-Doval I, Ortiz-Romero PL. [Translated article] Primary Cutaneous Lymphoma Registry of the Spanish Academy of Dermatology and Venereology (AEDV): Data for the First 5 Years. Actas Dermosifiliogr 2023; 114:T291-T298. [PMID: 36848951 DOI: 10.1016/j.ad.2022.11.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2022] [Accepted: 11/12/2022] [Indexed: 02/27/2023] Open
Abstract
BACKGROUND AND OBJECTIVE Primary cutaneous lymphomas (PCL) are uncommon. Observations based on the first year of data from the Spanish Registry of Primary Cutaneous Lymphomas (RELCP, in its Spanish abbreviation) of the Spanish Academy of Dermatology and Venereology (AEDV) were published in February 2018. This report covers RELCP data for the first 5 years. PATIENTS AND METHODS RELCP data were collected prospectively and included diagnosis, treatments, tests, and the current status of patients. We compiled descriptive statistics of the data registered during the first 5 years. RESULTS Information on 2020 patients treated at 33 Spanish hospitals had been included in the RELCP by December 2021. Fifty-nine percent of the patients were men; the mean age was 62.2 years. The lymphomas were grouped into 4 large diagnostic categories: mycosis fungoides/Sézary syndrome, 1112 patients (55%); primary B-cell cutaneous lymphoma, 547 patients (27.1%); primary CD30+ lymphoproliferative disorders, 222 patients (11%), and other T-cell lymphomas, 116 patients (5.8%). Nearly 75% of the tumors were registered in stage I. After treatment, 43.5% achieved complete remission and 27% were stable at the time of writing. Treatments prescribed were topical corticosteroids (1369 [67.8%]), phototherapy (890 patients [44.1%]), surgery (412 patients [20.4%]), and radiotherapy (384 patients [19%]). CONCLUSION The characteristics of cutaneous lymphomas in Spain are similar to those reported for other series. The large size of the RELCP registry at 5 years has allowed us to give more precise descriptive statistics than in the first year. This registry facilitates the clinical research of the AEDV's lymphoma interest group, which has already published articles based on the RELCP data.
Collapse
Affiliation(s)
- D Falkenhain-López
- Departamento de Dermatología, Hospital Universitario 12 de Octubre, Madrid, Spain.
| | - C Muniesa
- Departamento de Dermatología, Hospital Universitari de Bellvitge, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain
| | - M T Estrach
- Departamento de Dermatología, Hospital Clínico, IDIBAPS, Universitario de Barcelona, Barcelona, Spain
| | - M Morillo-Andújar
- Departamento de Dermatología, Hospital Virgen del Rocío, Sevilla, Spain
| | - Y Peñate
- Departamento de Dermatología, Complejo Hospitalario Universitario Insular Materno-Infantil, Gran Canaria, Spain
| | - E Acebo
- Departamento de Dermatología, Hospital Universitario de Cruces, Barakaldo, Bizkaia, Spain
| | - R M Pujol
- Departamento de Dermatología, Hospital del Mar, Barcelona, Spain
| | - M P García-Muret
- Departamento de Dermatología, Hospital Santa Creu i Sant Pau, UAB Barcelona, Barcelona, Spain
| | - S Machan
- Departamento de Dermatología, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
| | - S Medina
- Departamento de Dermatología, Hospital Universitario Príncipe de Asturias, Madrid, Spain
| | - R Botella-Estrada
- Departamento de Dermatología, Hospital Universitario La Fe, Valencia, Spain
| | - R Fernández de Misa
- Departamento de Dermatología, Hospital Universitario Nuestra Señora de la Candelaria, Tenerife, Spain
| | - M Blanes
- Departamento de Dermatología, Hospital General Universitario de Alicante, Alicante, Spain
| | - A Flórez
- Departamento de Dermatología, Complejo Hospitalario Universitario de Pontevedra, Pontevedra, Spain
| | - G Pérez-Paredes
- Departamento de Dermatología, Hospital Universitario Marqués de Valdecilla, Santander Cantabria, Spain
| | - R Izu
- Departamento de Dermatología, Hospital Universitario de Basurto, Bilbao, Bizkaia, Spain
| | - I Yanguas
- Departamento de Dermatología Complejo Hospitalario de Navarra, Navarra, Spain
| | - E Silva-Díaz
- Departamento de Dermatología, Hospital Clínico Universitario de Valencia, Valencia, Spain
| | - A Pérez-Ferriols
- Departamento de Dermatología, Hospital General Universitario de Valencia, Valencia, Spain
| | - L Prieto-Torres
- Departamento de Dermatología, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain
| | - A Zayas
- Departamento de Dermatología, Hospital Universitario Dr. Peset, Valencia, Spain
| | - M E Parera-Amer
- Departamento de Dermatología, Hospital Universitario Son Llàtzer, Palma, Islas Baleares, Spain
| | - A Pérez
- Departamento de Dermatología, Hospital Universitario Nuestra Señora De Valme, Sevilla, Spain
| | - L Aspe
- Departamento de Dermatología, Hospital Universitario de Araba, Vitoria-Gasteiz, Álava, Spain
| | - C Román
- Departamento de Dermatología, Hospital Universitario de Salamanca, Salamanca, Spain
| | - M P Sánchez-Caminero
- Departamento de Dermatología, Hospital General de Ciudad Real, Ciudad Real, Spain
| | - J Bassas-Vila
- Departamento de Dermatología, Hospital Germans Trias i Pujol, Barcelona, Spain
| | - J D Domínguez-Auñón
- Departamento de Dermatología, Hospital Universitario del Henares, Coslada, Madrid, Spain
| | - L Calzado
- Departamento de Dermatología, Hospital Universitario de Torrejón, Torrejón de Ardoz, Madrid, Spain
| | - M Navedo
- Departamento de Dermatología, Complejo Asistencial Universitario de León, León, Spain
| | - A Ortiz-Prieto
- Departamento de Dermatología, Hospital Puerta del Mar, Cádiz, Spain
| | - O Servitje
- Departamento de Dermatología, Hospital Universitari de Bellvitge, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain
| | - I Polo-Rodríguez
- Departamento de Dermatología, Hospital Universitario Príncipe de Asturias, Madrid, Spain
| | - I Torres
- Departamento de Dermatología, Hospital Universitario La Fe, Valencia, Spain
| | - M N Hernández-Hernández
- Departamento de Dermatología, Hospital Universitario Nuestra Señora de la Candelaria, Tenerife, Spain
| | - J Mitxelena-Eceiza
- Departamento de Dermatología Complejo Hospitalario de Navarra, Navarra, Spain
| | - A García-Vázquez
- Departamento de Dermatología, Hospital Clínico Universitario de Valencia, Valencia, Spain
| | - I García-Doval
- Unidad de Investigación, Fundación Piel Sana AEDV, León, Spain; Departamento de Dermatología, Complejo Hospitalario Universitario de Vigo, Vigo, Pontevedra, Spain
| | - P L Ortiz-Romero
- Departamento de Dermatología, Hospital Universitario 12 de Octubre, Madrid, Spain
| |
Collapse
|
10
|
Falkenhain-López D, Muniesa C, Estrach MT, Morillo-Andújar M, Peñate Y, Acebo E, Pujol RM, García-Muret MP, Machan S, Medina S, Botella-Estrada R, Fernández de Misa R, Blanes M, Flórez A, Pérez-Paredes G, Izu R, Yanguas I, Silva-Díaz E, Pérez-Ferriols A, Prieto-Torres L, Zayas A, Parera-Amer ME, Pérez A, Aspe L, Román C, Sánchez-Caminero MP, Bassas-Vila J, Domínguez-Auñón JD, Calzado L, Navedo M, Ortiz-Prieto A, Servitje O, Polo-Rodríguez I, Torres I, Hernández-Hernández MN, Mitxelena-Eceiza J, García-Vázquez A, García-Doval I, Ortiz-Romero PL. Primary Cutaneous Lymphoma Registry of the Spanish Academy of Dermatology and Venereology (AEDV): Data for the First 5 Years. Actas Dermosifiliogr 2022; 114:291-298. [PMID: 36529273 DOI: 10.1016/j.ad.2022.11.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2022] [Revised: 11/09/2022] [Accepted: 11/12/2022] [Indexed: 12/23/2022] Open
Abstract
BACKGROUND AND OBJECTIVE Primary cutaneous lymphomas (PCL) are uncommon. Observations based on the first year of data from the Spanish Registry of Primary Cutaneous Lymphomas (RELCP, in its Spanish abbreviation) of the Spanish Academy of Dermatology and Venereology (AEDV) were published in February 2018. This report covers RELCP data for the first 5 years. PATIENTS AND METHODS RELCP data were collected prospectively and included diagnosis, treatments, tests, and the current status of patients. We compiled descriptive statistics of the data registered during the first 5 years. RESULTS Information on 2020 patients treated at 33 Spanish hospitals had been included in the RELCP by December 2021. Fifty-nine percent of the patients were men; the mean age was 62.2 years. The lymphomas were grouped into 4 large diagnostic categories: mycosis fungoides/Sézary syndrome, 1112 patients (55%); primary B-cell cutaneous lymphoma, 547 patients (27.1%); primary CD30+lymphoproliferative disorders, 222 patients (11%), and other T-cell lymphomas, 116 patients (5.8%). Nearly 75% of the tumors were registered in stage I. After treatment, 43.5% achieved complete remission and 27% were stable at the time of writing. Treatments prescribed were topical corticosteroids (1369 [67.8%]), phototherapy (890 patients [44.1%]), surgery (412 patients [20.4%]), and radiotherapy (384 patients [19%]). CONCLUSION The characteristics of cutaneous lymphomas in Spain are similar to those reported for other series. The large size of the RELCP registry at 5 years has allowed us to give more precise descriptive statistics than in the first year. This registry facilitates the clinical research of the AEDV's lymphoma interest group, which has already published articles based on the RELCP data.
Collapse
Affiliation(s)
- D Falkenhain-López
- Departamento de Dermatología, Hospital Universitario 12 de Octubre, Madrid, España.
| | - C Muniesa
- Departamento de Dermatología, Hospital Universitari de Bellvitge, IDIBELL, L'Hospitalet de Llobregat, Barcelona, España
| | - M T Estrach
- Departamento de Dermatología, Hospital Clínico, IDIBAPS, Universitario de Barcelona, Barcelona, España
| | - M Morillo-Andújar
- Departamento de Dermatología, Hospital Virgen del Rocío, Sevilla, España
| | - Y Peñate
- Departamento de Dermatología, Complejo Hospitalario Universitario Insular Materno-Infantil, Gran Canaria, España
| | - E Acebo
- Departamento de Dermatología, Hospital Universitario de Cruces, Barakaldo, Bizkaia, España
| | - R M Pujol
- Departamento de Dermatología, Hospital del Mar, Barcelona, España
| | - M P García-Muret
- Departamento de Dermatología, Hospital Santa Creu i Sant Pau, UAB Barcelona, Barcelona, España
| | - S Machan
- Departamento de Dermatología, Hospital Universitario Fundación Jiménez Díaz, Madrid, España
| | - S Medina
- Departamento de Dermatología, Hospital Universitario Príncipe de Asturias, Madrid, España
| | - R Botella-Estrada
- Departamento de Dermatología, Hospital Universitario La Fe, Valencia, España
| | - R Fernández de Misa
- Departamento de Dermatología, Hospital Universitario Nuestra Señora de la Candelaria, Tenerife, España
| | - M Blanes
- Departamento de Dermatología, Hospital General Universitario de Alicante, Alicante, España
| | - A Flórez
- Departamento de Dermatología, Complejo Hospitalario Universitario de Pontevedra, Pontevedra, España
| | - G Pérez-Paredes
- Departamento de Dermatología, Hospital Universitario Marqués de Valdecilla, Santander Cantabria, España
| | - R Izu
- Departamento de Dermatología, Hospital Universitario de Basurto, Bilbao, Bizkaia, España
| | - I Yanguas
- Departamento de Dermatología Complejo Hospitalario de Navarra, Navarra, España
| | - E Silva-Díaz
- Departamento de Dermatología, Hospital Clínico Universitario de Valencia, Valencia, España
| | - A Pérez-Ferriols
- Departamento de Dermatología, Hospital General Universitario de Valencia, Valencia, España
| | - L Prieto-Torres
- Departamento de Dermatología, Hospital Clínico Universitario Lozano Blesa, Zaragoza, España
| | - A Zayas
- Departamento de Dermatología, Hospital Universitario Dr. Peset, Valencia, España
| | - M E Parera-Amer
- Departamento de Dermatología, Hospital Universitario Son Llàtzer, Palma, Islas Baleares, España
| | - A Pérez
- Departamento de Dermatología, Hospital Universitario Nuestra Señora De Valme, Sevilla, España
| | - L Aspe
- Departamento de Dermatología, Hospital Universitario de Araba, Vitoria-Gasteiz, Álava, España
| | - C Román
- Departamento de Dermatología, Hospital Universitario de Salamanca, Salamanca, España
| | - M P Sánchez-Caminero
- Departamento de Dermatología, Hospital General de Ciudad Real, Ciudad Real, España
| | - J Bassas-Vila
- Departamento de Dermatología, Hospital Germans Trias i Pujol, Barcelona, España
| | - J D Domínguez-Auñón
- Departamento de Dermatología, Hospital Universitario del Henares, Coslada, Madrid, España
| | - L Calzado
- Departamento de Dermatología, Hospital Universitario de Torrejón, Torrejón de Ardoz, Madrid, España
| | - M Navedo
- Departamento de Dermatología, Complejo Asistencial Universitario de León, León, España
| | - A Ortiz-Prieto
- Departamento de Dermatología, Hospital Puerta del Mar, Cádiz, España
| | - O Servitje
- Departamento de Dermatología, Hospital Universitari de Bellvitge, IDIBELL, L'Hospitalet de Llobregat, Barcelona, España
| | - I Polo-Rodríguez
- Departamento de Dermatología, Hospital Universitario Príncipe de Asturias, Madrid, España
| | - I Torres
- Departamento de Dermatología, Hospital Universitario La Fe, Valencia, España
| | - M N Hernández-Hernández
- Departamento de Dermatología, Hospital Universitario Nuestra Señora de la Candelaria, Tenerife, España
| | - J Mitxelena-Eceiza
- Departamento de Dermatología Complejo Hospitalario de Navarra, Navarra, España
| | - A García-Vázquez
- Departamento de Dermatología, Hospital Clínico Universitario de Valencia, Valencia, España
| | - I García-Doval
- Unidad de Investigación, Fundación Piel Sana AEDV, León, España; Departamento de Dermatología, Complejo Hospitalario Universitario de Vigo, Vigo, Pontevedra, España
| | - P L Ortiz-Romero
- Departamento de Dermatología, Hospital Universitario 12 de Octubre, Madrid, España
| |
Collapse
|
11
|
Lopez‐Trujillo E, Pesqué D, Sanchez F, Dominguez M, Gallardo F, Pujol RM, Ferran M. Active tuberculosis in a cohort of patients with psoriasis on biologic therapy: learnings from real‐life medical practice. J Eur Acad Dermatol Venereol 2022; 36:e689-e691. [DOI: 10.1111/jdv.18131] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2022] [Accepted: 04/06/2022] [Indexed: 11/26/2022]
Affiliation(s)
- E Lopez‐Trujillo
- Department of Dermatology, Hospital del Mar, Parc de Salut Mar Barcelona Spain
| | - D Pesqué
- Department of Dermatology, Hospital del Mar, Parc de Salut Mar Barcelona Spain
| | - F Sanchez
- Department of Infectious diseases, Hospital del Mar, Parc de Salut Mar Barcelona Spain
| | - M Dominguez
- Department of Pneumology, Hospital del Mar, Parc de Salut Mar Barcelona Spain
| | - F Gallardo
- Department of Dermatology, Hospital del Mar, Parc de Salut Mar Barcelona Spain
| | - RM Pujol
- Department of Dermatology, Hospital del Mar, Parc de Salut Mar Barcelona Spain
| | - M Ferran
- Department of Dermatology, Hospital del Mar, Parc de Salut Mar Barcelona Spain
| |
Collapse
|
12
|
Pesqué D, Lopez-Trujillo E, Marcantonio O, Giménez-Arnau AM, Pujol RM. New-onset and exacerbations of psoriasis after mRNA COVID-19 vaccines: two sides of the same coin? J Eur Acad Dermatol Venereol 2021; 36:e80-e81. [PMID: 34547146 DOI: 10.1111/jdv.17690] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2021] [Accepted: 09/16/2021] [Indexed: 01/31/2023]
Affiliation(s)
- D Pesqué
- Department of Dermatology, Hospital del Mar- Institut Mar d'Investigacions Mèdiques, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain
| | - E Lopez-Trujillo
- Department of Dermatology, Hospital del Mar- Institut Mar d'Investigacions Mèdiques, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain
| | - O Marcantonio
- Department of Dermatology, Hospital del Mar- Institut Mar d'Investigacions Mèdiques, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain
| | - A M Giménez-Arnau
- Department of Dermatology, Hospital del Mar- Institut Mar d'Investigacions Mèdiques, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain
| | - R M Pujol
- Department of Dermatology, Hospital del Mar- Institut Mar d'Investigacions Mèdiques, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain
| |
Collapse
|
13
|
Marcantonio-Santa Cruz OY, Vidal-Navarro A, Pesqué D, Giménez-Arnau AM, Pujol RM, Martin-Ezquerra G. Pityriasis rosea developing after COVID-19 vaccination. J Eur Acad Dermatol Venereol 2021; 35:e721-e722. [PMID: 34237178 PMCID: PMC8447432 DOI: 10.1111/jdv.17498] [Citation(s) in RCA: 19] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2021] [Revised: 06/08/2021] [Accepted: 06/25/2021] [Indexed: 01/02/2023]
Affiliation(s)
- O Y Marcantonio-Santa Cruz
- Dermatology Department, Hospital del Mar, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona, Barcelona, Spain
| | - A Vidal-Navarro
- Dermatology Department, Hospital del Mar, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona, Barcelona, Spain
| | - D Pesqué
- Dermatology Department, Hospital del Mar, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona, Barcelona, Spain
| | - A M Giménez-Arnau
- Dermatology Department, Hospital del Mar, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona, Barcelona, Spain
| | - R M Pujol
- Dermatology Department, Hospital del Mar, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona, Barcelona, Spain
| | - G Martin-Ezquerra
- Dermatology Department, Hospital del Mar, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona, Barcelona, Spain
| |
Collapse
|
14
|
Martin-Ezquerra G, Monreal P, Mercuriali L, Cañas-Ruano E, Pujol RM, Duran X, Masferrer Niubò M, Domingo P, Villar-Garcia J, Lopez-Contreras J, Gonzalez-Cordón A, Garcia-Olalla P, Barberá MJ. Evolution of notified sexually transmitted infections in Barcelona during the first wave of the COVID-19 pandemic. J Eur Acad Dermatol Venereol 2021; 35:e642-e645. [PMID: 34146425 PMCID: PMC8447417 DOI: 10.1111/jdv.17460] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- G Martin-Ezquerra
- Dermatology Department, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Hospital del Mar, Barcelona, Spain
| | - P Monreal
- Dermatology Department, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Hospital del Mar, Barcelona, Spain
| | - L Mercuriali
- Epidemiology Service, Public Health Agency of Barcelona (ASPB), Barcelona, Spain
| | - E Cañas-Ruano
- Department of Infectious Diseases, Hospital Universitari Vall d'Hebron, Barcelona, Spain.,Vall d'Hebron Institut de Recerca, Barcelona, Spain.,Universitat Autònoma de Barcelona, Barcelona, Spain
| | - R M Pujol
- Dermatology Department, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Hospital del Mar, Barcelona, Spain
| | - X Duran
- Scientifics, Statistics and Technical Department, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Hospital del Mar, Barcelona, Spain
| | - M Masferrer Niubò
- Facultat de Ciències, Seu de Barcelona, Universidad Nacional de Educación a Distancia (UNED), Barcelona, Spain
| | - P Domingo
- Infectious Diseases Unit-Internal Medicine Department, Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, Barcelona, Spain
| | - J Villar-Garcia
- Department of Infectious Diseases, Hospital del Mar, Barcelona, Spain
| | - J Lopez-Contreras
- Infectious Diseases Unit-Internal Medicine Department, Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, Barcelona, Spain
| | | | - P Garcia-Olalla
- Epidemiology Service, Public Health Agency of Barcelona (ASPB), Barcelona, Spain.,Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain
| | - M-J Barberá
- Department of Infectious Diseases, Hospital Universitari Vall d'Hebron, Barcelona, Spain.,Vall d'Hebron Institut de Recerca, Barcelona, Spain.,Universitat Autònoma de Barcelona, Barcelona, Spain
| | | |
Collapse
|
15
|
Puig L, Ferrándiz C, Pujol RM, Vela E, Albertí-Casas C, Comellas M, Blanch C. Burden of Psoriasis in Catalonia: Epidemiology, Associated Comorbidities, Health Care Utilization, and Sick Leave. Actas Dermosifiliogr (Engl Ed) 2020; 112:425-433. [PMID: 33290733 DOI: 10.1016/j.ad.2020.11.017] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2020] [Revised: 11/23/2020] [Accepted: 11/29/2020] [Indexed: 01/19/2023] Open
Abstract
BACKGROUND AND OBJECTIVES Epidemiologic and disease burden data are essential for disease control and optimal health care resource planning. The aims of this study were to estimate the epidemiologic burden of psoriasis and evaluate associated comorbidities, health care utilization, and sick leave. MATERIAL AND METHODS We collected data from the 2016 Catalan Health Survey (ESCA), the Catalan Registry of Morbidity and Utilization of Health Care Services (MUSSCAT) (2016), and the database of the Catalan Medical Evaluations Institute (ICAM) (2012-2016). RESULTS The prevalence of psoriasis in Catalonia according to 2016 ESCA data is approximately 1.8%. The MUSSCAT registry data indicate that the incidence has remained stable in recent years. The most common comorbidities associated with psoriasis are hypertension (35%) and diabetes (15%). Forty percent of patients with psoriasis have a moderate to high risk for death or high health resource utilization. Annual use of resources by psoriasis patients is high: they make a mean of 8.7 primary care visits, 2.8 outpatient visits, 0.5 emergency and day hospital visits, 0.2 mental health visits, and use 6.1 medications. Sick leave due to psoriasis or psoriatic arthritis accounted for 0.04% of all cases. CONCLUSIONS The prevalence of psoriasis in Catalonia is high at 1.8%. The disease burden is also high, both in terms of comorbidities and health care utilization.
Collapse
Affiliation(s)
- L Puig
- Servicio de Dermatología, Hospital de la Santa Creu i Sant Pau, Barcelona, España
| | - C Ferrándiz
- Servicio de Dermatología, Hospital Universitari Germans Trías i Pujol (HUGiT), Badalona, España
| | - R M Pujol
- Servicio de Dermatología, Hospital del Mar, Barcelona, España
| | - E Vela
- Àrea de Sistemes d'Informació, Servei Català de la Salut, Barcelona, España
| | - C Albertí-Casas
- Subdirecció General d'Avaluacions Mėdiques, Departament de Salut, Barcelona, España
| | - M Comellas
- Outcomes'10, Espaitec 2, Universitat Jaume 1, Castelló de la Plana, España
| | - C Blanch
- Health Economics & Market Access Novartis Farmacéutica, Barcelona, España.
| |
Collapse
|
16
|
Arimany-Manso J, Pujol RM, García-Patos V, Saigí U, Martin-Fumadó C. Medicolegal Aspects of Teledermatology. Actas Dermosifiliogr (Engl Ed) 2020; 111:815-821. [PMID: 32910922 PMCID: PMC7476561 DOI: 10.1016/j.ad.2020.08.008] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2020] [Revised: 07/13/2020] [Accepted: 08/28/2020] [Indexed: 12/19/2022] Open
Abstract
Teledermatology has facilitated specialist care during the crisis caused by the coronavirus disease 2019 pandemic, eliminating unnecessary office visits and the possible exposure of patients or dermatologists. However, teledermatology brings forward certain ethical and medicolegal questions. A medical consultation in which the patient is not physically present is still a medical act, to which all the usual ethical and medicolegal considerations and consequences apply. The patient's right to autonomy and privacy, confidentiality, and data protection must be guaranteed. The patient must agree to remote consultation by giving informed consent, for which a safeguard clause should be included. Well-defined practice guidelines and uniform legislation are required to preserve the highest level of safety for transferred data. Adequate training is also needed to prevent circumstances involving what might be termed «telemalpractice».
Collapse
Affiliation(s)
- J Arimany-Manso
- Servicio de Responsabilidad Profesional, Área de Praxis, Colegio de Médicos de Barcelona, Consejo de Colegios de Médicos de Catalunya, Barcelona, España; Unidad de Medicina Legal y Forense, Departamento de Salud Pública, Facultad de Medicina, Universidad de Barcelona, Barcelona, España; Cátedra de Responsabilidad Profesional Médica y Medicina Legal, Universitat Autònoma de Barcelona (UAB), Barcelona, España
| | - R M Pujol
- Servicio de Dermatología, Hospital del Mar. Parc de Salut Mar, Institut Mar d'Investigació Mèdica, Universitat Autònoma de Barcelona, Barcelona, España
| | - V García-Patos
- Servicio de Dermatología, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, España
| | - U Saigí
- Servicio de Responsabilidad Profesional, Área de Praxis, Colegio de Médicos de Barcelona, Consejo de Colegios de Médicos de Catalunya, Barcelona, España
| | - C Martin-Fumadó
- Servicio de Responsabilidad Profesional, Área de Praxis, Colegio de Médicos de Barcelona, Consejo de Colegios de Médicos de Catalunya, Barcelona, España; Cátedra de Responsabilidad Profesional Médica y Medicina Legal, Universitat Autònoma de Barcelona (UAB), Barcelona, España; Departamento de Medicina, Facultad de Medicina, Universitat Internacional de Catalunya, Barcelona, España.
| |
Collapse
|
17
|
Porcar Saura S, March-Rodríguez A, Pujol RM, Segura Tigell S. Two-Step Digital Follow-up of Patients at High Risk for Melanoma: a Retrospective Analysis of 152 Patients. Actas Dermosifiliogr (Engl Ed) 2020; 112:250-256. [PMID: 33197436 DOI: 10.1016/j.ad.2020.11.004] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2020] [Revised: 10/14/2020] [Accepted: 11/02/2020] [Indexed: 01/14/2023] Open
Abstract
BACKGROUND Digital dermoscopy (DD) has been found to improve the accuracy of melanoma diagnosis in high-risk patients. A 2-step approach combining DD and total-body photography (TBP) can facilitate the detection of new lesions or early macroscopic changes in existing lesions. OBJECTIVES The aim of this study was to determine the number of biopsies needed to diagnose melanoma and to describe the clinical and dermoscopic characteristics of melanoma diagnosed in patients with pigmented lesions under follow-up with DD and TBP. PATIENTS AND METHODS Retrospective study of 152 patients with a high risk of melanoma who were followed using a 2-step digital approach at Hospital del Mar in Barcelona, Spain, between 2002 and 2016. We analyzed the characteristics of pigmented lesions excised after macroscopic changes were detected by periodic DD and TBD. RESULTS Biopsy results of 99 lesions (84 dysplastic nevi, 13 melanomas, and 2 compound melanocytic nevi) showed a ratio of benign melanocytic lesions to melanomas of 1:6.6. The mean Breslow thickness was 0.19 mm. Macroscopic changes were significantly more common in melanomas than in melanocytic nevi (P = 0.018). Dermoscopic findings associated with melanoma were asymmetric growth and focal structural changes (P < 0.001). The specific features associated with a diagnosis of melanoma were asymmetry (P < 0.001), a reverse pigment network (P = 0.011), atypical globules (P = 0.011), and polymorphous vessels (P = 0.045). CONCLUSIONS TBP follow-up is a useful tool for the early diagnosis of melanoma. In our series, 50% of melanomas diagnosed during digital follow-up were detected by observation of a new lesion via TBP mapping or macroscopic changes in an existing lesion. Dermoscopic follow-up is essential in patients at high risk for melanoma as both melanocytic nevi and melanoma show a range of specific dermoscopic features, and a diagnosis of melanoma can only be based on a record of changes in the appearance of lesions during follow-up.
Collapse
Affiliation(s)
- S Porcar Saura
- Servicio de Dermatología, Hospital Clínico Universitario de Valencia, Universidad de Valencia, Valencia, España.
| | | | - R M Pujol
- Servicio de Dermatología, Hospital del Mar, IMIM, Barcelona, España
| | - S Segura Tigell
- Servicio de Dermatología, Hospital del Mar, IMIM, Barcelona, España
| |
Collapse
|
18
|
Arimany-Manso J, Pujol RM, García-Patos V, Saigí U, Martin-Fumadó C. Medicolegal aspects of teledermatology. Actas Dermosifiliogr 2020. [PMID: 34012149 PMCID: PMC7836632 DOI: 10.1016/j.adengl.2020.08.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022] Open
Abstract
Teledermatology has facilitated specialist care during the crisis caused by the coronavirus disease 2019 pandemic, eliminating unnecessary office visits and the possible exposure of patients or dermatologists. However, teledermatology brings forward certain ethical and medicolegal questions. A medical consultation in which the patient is not physically present is still a medical act, to which all the usual ethical and medicolegal considerations and consequences apply. The patient's right to autonomy and privacy, confidentiality, and data protection must be guaranteed. The patient must agree to remote consultation by giving informed consent, for which a safeguard clause should be included. Well-defined practice guidelines and uniform legislation are required to preserve the highest level of safety for transferred data. Adequate training is also needed to prevent circumstances involving what might be termed "telemalpractice."
Collapse
Affiliation(s)
- J Arimany-Manso
- Servicio de Responsabilidad Profesional, Área de Praxis, Colegio de Médicos de Barcelona, Consejo de Colegios de Médicos de Catalunya, Barcelona, Spain.,Unidad de Medicina Legal y Forense, Departamento de Salud Pública, Facultad de Medicina, Universidad de Barcelona, Barcelona, Spain.,Cátedra de Responsabilidad Profesional Médica y Medicina Legal, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain
| | - R M Pujol
- Servicio de Dermatología, Parc de Salut Mar, Institut Municipal d'Investigació Mèdica, Universitat Autònoma de Barcelona, Barcelona, Spain
| | - V García-Patos
- Servicio de Dermatología, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain
| | - U Saigí
- Servicio de Responsabilidad Profesional, Área de Praxis, Colegio de Médicos de Barcelona, Consejo de Colegios de Médicos de Catalunya, Barcelona, Spain
| | - C Martin-Fumadó
- Servicio de Responsabilidad Profesional, Área de Praxis, Colegio de Médicos de Barcelona, Consejo de Colegios de Médicos de Catalunya, Barcelona, Spain.,Cátedra de Responsabilidad Profesional Médica y Medicina Legal, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.,Departamento de Medicina, Facultad de Medicina, Universitat Internacional de Catalunya, Barcelona, Spain
| |
Collapse
|
19
|
Bertolín-Colilla M, Garin-Boronat O, Siebenhaar F, Maurer M, Pujol RM, Giménez-Arnau AM. Translation and Cultural Adaptation of the German Mastocytosis Quality of Life Questionnaire (MC-QoL) into Spanish. Actas Dermosifiliogr (Engl Ed) 2020; 111:243-248. [PMID: 31987469 DOI: 10.1016/j.ad.2019.11.003] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2019] [Revised: 11/18/2019] [Accepted: 11/20/2019] [Indexed: 11/15/2022] Open
Abstract
BACKGROUND Mastocytosis encompasses a spectrum of disorders in which different organs and tissues are affected by the clonal expansion of mast cells. The skin is one of the most frequently affected organs. The clinical manifestations of mastocytosis are linked to the release of proinflammatory mediators, and the impact of this disorder on patient quality of life has been described in various studies. The Mastocytosis Quality of Life Questionnaire (MC-QoL), which was recently developed in Germany and now also exists in English, is an important tool for evaluating the psychosocial impact of this disease. OBJECTIVE To create a Spanish version of the MC-QoL that was culturally equivalent to the original German questionnaire. MATERIAL AND METHODS The adaptation process, which involved forward translation, cognitive interviews, and back translation, was conducted in accordance with the principles of good practice for the translation and cultural adaptation of patient-reported measures of the International Society for Pharmacoeconomics and Outcomes Research. The MC-QoL contains 27 items in 4 domains: symptoms, emotions, social life/functioning, and skin. RESULTS The first version of the Spanish questionnaire, obtained by forward translation from German, was tested in cognitive interviews, after which 3 items were modified to make them easier to understand. The German back translation of the Spanish questionnaire was analyzed by the authors of the original MC-QoL, who modified 1 item they considered to have lost specificity in the adaptation process. The definitive Spanish MC-QoL was then produced following minor modifications agreed on with the German authors. CONCLUSION We have produced a cultural adaptation of the MC-QoL in Spanish that can be used in routine clinical practice to obtain a more complete picture of the impact of mastocytosis on patient quality of life.
Collapse
Affiliation(s)
- M Bertolín-Colilla
- Departamento de Dermatología, Hospital del Mar, Parc de Salut Mar, IMIM, Universitat Autònoma de Barcelona
| | - O Garin-Boronat
- Grupo de Investigación en Servicios Sanitarios, Instituto Hospital del Mar de Investigaciones Médicas
| | - F Siebenhaar
- Departamento de Dermatología y Alergia, Allergie-Centrum-Charité, Charité-Universitätsmedizin, Berlín, Alemania
| | - M Maurer
- Departamento de Dermatología y Alergia, Allergie-Centrum-Charité, Charité-Universitätsmedizin, Berlín, Alemania
| | - R M Pujol
- Departamento de Dermatología, Hospital del Mar, Parc de Salut Mar, IMIM, Universitat Autònoma de Barcelona
| | - A M Giménez-Arnau
- Departamento de Dermatología, Hospital del Mar, Parc de Salut Mar, IMIM, Universitat Autònoma de Barcelona.
| |
Collapse
|
20
|
Fernández-de-Misa R, Hernández-Machín B, Combalía A, García Muret MP, Servitje O, Muniesa C, Gallardo F, Pujol RM, Martí RM, Ortiz-Brugués A, Maroñas-Jiménez L, Ortiz-Romero PL, Blanch Rius L, Izu R, Román C, Cañueto J, Blanes M, Morillo M, Bastida J, Peñate Y, Pérez Gala S, Espinosa Lara P, Pérez Gil A, Estrach T. Prognostic factors in patients with primary cutaneous anaplastic large cell lymphoma: a multicentric, retrospective analysis of the Spanish Group of Cutaneous Lymphoma. J Eur Acad Dermatol Venereol 2019; 34:762-768. [PMID: 31591786 DOI: 10.1111/jdv.16006] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2019] [Accepted: 09/25/2019] [Indexed: 11/29/2022]
Abstract
BACKGROUND Reliable prognostic factors for patients with primary cutaneous anaplastic large cell lymphoma (PCALCL) are lacking. OBJECTIVE To identify prognostic factors for specific survival in patients with PCALCL. METHODS Using the convenience sampling method, patients with PCALCL diagnosed from May 1986 to August 2017 in 16 University Departments were retrospectively reviewed. RESULTS One hundred eight patients were included (57 males). Median age at diagnosis was 58 years. All of them showed T1-3N0M0 stages. Seventy per cent of the cases presented with a solitary lesion, mostly at the limbs. Complete response rate after first-line treatment was 87%, and no advantage was observed for any of them (surgery, radiotherapy, chemotherapy or other approaches). Nodal and visceral progression rate was 11% and 2%, respectively. 5-year specific survival (SSV) reached 93%; 97% for T1 patients and 84% for T2/T3 patients (P = 0.031). Five-year SSV for patients developing early cutaneous relapse was 64%; for those with late or no relapse, 96% (P = 0.001). Estimated median SSV for patients showing nodal progression was 103 months (95% CI: 51-155 months); for patients without nodal progression, estimated SSV did not reach the median (P < 0.001). Nodal progression was an independent predictive parameter for shorter survival (P = 0.011). CONCLUSION Multiple cutaneous lesions at presentation, early skin relapse and nodal progression portrait worse prognosis in patients with PCALCL.
Collapse
Affiliation(s)
- R Fernández-de-Misa
- Department of Dermatology and Research Unit, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain
| | - B Hernández-Machín
- Department of Dermatology, Sefton Suite, DMC Healthcare, NHS Trust Liverpool, Liverpool, UK
| | - A Combalía
- Department of Dermatology, Hospital Clínico, University of Barcelona, Barcelona, Spain
| | - M P García Muret
- Department of Dermatology, Hospital Santa Creu i Sant Pau, UAB, Barcelona, Spain
| | - O Servitje
- Department of Dermatology, Hospital Universitari de Bellvitge, IDIBELL, Barcelona, Spain
| | - C Muniesa
- Department of Dermatology, Hospital Universitari de Bellvitge, IDIBELL, Barcelona, Spain
| | - F Gallardo
- Department of Dermatology, Hospital del Mar, Universitat Autónoma de Barcelona, Barcelona, Spain
| | - R M Pujol
- Department of Dermatology, Hospital del Mar, Universitat Autónoma de Barcelona, Barcelona, Spain
| | - R M Martí
- Department of Dermatology, Hospital Univeritari Arnau de Vilanova, IRBLleida, Lleida, Spain.,Centre of Biomedical Research on Cancer (CIBERONC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain
| | - A Ortiz-Brugués
- Department of Dermatology, Hospital Univeritari Arnau de Vilanova, IRBLleida, Lleida, Spain
| | - L Maroñas-Jiménez
- Department of Dermatology, Hospital Universitario 12 de Octubre, i+12 Research Institute, Universidad Complutense, Madrid, Spain
| | - P L Ortiz-Romero
- Centre of Biomedical Research on Cancer (CIBERONC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.,Department of Dermatology, Hospital Universitario 12 de Octubre, i+12 Research Institute, Universidad Complutense, Madrid, Spain
| | - L Blanch Rius
- Department of Dermatology, Hospital de Basurto, Bilbao, Spain
| | - R Izu
- Department of Dermatology, Hospital de Basurto, Bilbao, Spain
| | - C Román
- Department of Dermatology, Hospital Universitario de Salamanca, Salamanca, Spain
| | - J Cañueto
- Department of Dermatology, Hospital Universitario de Salamanca, Salamanca, Spain
| | - M Blanes
- Department of Dermatology, Hospital General Universitario de Alicante, Alicante, Spain
| | - M Morillo
- Department of Dermatology, Hospital Universitario Virgen del Rocío, Sevilla, Spain
| | - J Bastida
- Department of Dermatology, Hospital Universitario Dr. Negrín, Las Palmas de Gran Canaria, Spain
| | - Y Peñate
- Department of Dermatology, Complejo Hospitalario Universitario Insular Materno-Infantil, Las Palmas de G.C, Spain
| | - S Pérez Gala
- Department of Dermatology, Hospital Universitario Ramón y Cajal, Madrid, Spain
| | - P Espinosa Lara
- Department of Dermatology, Hospital Universitario Infanta Cristina, Parla, Madrid, Spain
| | - A Pérez Gil
- Department of Dermatology, Hospital Virgen de Valme, Sevilla, Spain
| | - T Estrach
- Department of Dermatology, Hospital Clínico, IDIBAPS, University of Barcelona, Barcelona, Spain
| |
Collapse
|
21
|
Lobato-Berezo A, Fernández Figueras MT, Moreno Romero JA, Pujol RM. Pemphigoid Gestationis Mimicking Erythema Multiforme With Mucosal Involvement. Actas Dermosifiliogr (Engl Ed) 2019; 110:696-697. [PMID: 30732852 DOI: 10.1016/j.ad.2018.02.038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2017] [Revised: 01/15/2018] [Accepted: 02/11/2018] [Indexed: 10/27/2022] Open
Affiliation(s)
- A Lobato-Berezo
- Departamento de Dermatología, Hospital del Mar-Parc Salut Mar, Barcelona, España; Departamento de Dermatología, Hospital Universitari General de Catalunya, Sant Cugat del Vallès, Barcelona, España.
| | - M T Fernández Figueras
- Departamento de Anatomía Patológica, Hospital Universitari General de Catalunya, Sant Cugat del Vallès, Barcelona, España
| | - J A Moreno Romero
- Departamento de Dermatología, Hospital Universitari General de Catalunya, Sant Cugat del Vallès, Barcelona, España
| | - R M Pujol
- Departamento de Dermatología, Hospital del Mar-Parc Salut Mar, Barcelona, España
| |
Collapse
|
22
|
Lobato-Berezo A, Vidal Navarro A, Pujol RM. Image Gallery: Red coral vascular pattern as a new dermoscopic clue for clear cell acanthoma. Br J Dermatol 2019; 180:e4. [PMID: 30604543 DOI: 10.1111/bjd.17153] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Affiliation(s)
- A Lobato-Berezo
- Department of Dermatology, Hospital del Mar-Parc de Salut Mar, Passeig Marítim 25-29, 08003, Barcelona, Spain.,Department of Dermatology, Hospital Universitari General de Catalunya, Carrer Pedro I Pons 1, 08195, Sant Cugat del Vàlles, Barcelona, Spain
| | - A Vidal Navarro
- Department of Dermatology, Hospital del Mar-Parc de Salut Mar, Passeig Marítim 25-29, 08003, Barcelona, Spain
| | - R M Pujol
- Department of Dermatology, Hospital del Mar-Parc de Salut Mar, Passeig Marítim 25-29, 08003, Barcelona, Spain
| |
Collapse
|
23
|
Deza G, Notario J, Lopez-Ferrer A, Vilarrasa E, Ferran M, Del Alcazar E, Carrascosa JM, Corral M, Salleras M, Ribera M, Puig L, Pujol RM, Vidal D, Gallardo F. Initial results of ixekizumab efficacy and safety in real-world plaque psoriasis patients: a multicentre retrospective study. J Eur Acad Dermatol Venereol 2018; 33:553-559. [PMID: 30317679 DOI: 10.1111/jdv.15288] [Citation(s) in RCA: 26] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2018] [Accepted: 09/27/2018] [Indexed: 01/13/2023]
Abstract
BACKGROUND Ixekizumab (anti-IL17A) is effective as treatment for moderate-to-severe plaque psoriasis, but real-life data on effectiveness and safety are currently very limited. OBJECTIVE To evaluate the efficacy and safety of ixekizumab in a cohort of real-life plaque psoriasis patients. METHODS Retrospective chart review of 100 patients with moderate-to-severe plaque psoriasis treated with ixekizumab at seven Spanish dermatological centres. RESULTS According to the as observed analysis, the percentage of patients achieving a 75% and 90% of reduction from the baseline score of Psoriasis Area and Severity Index (PASI) was 87.5%-50.0% at week 12-16; 88.3%-58.4% at week 24 and 82.9%-58.5% at week 52, respectively. The mean ± standard deviation (SD) score of PASI at baseline was 12.9 ± 9.2, and it declined rapidly after ixekizumab administration to 1.9 ± 4.0 (P < 0.001) at week 12-16 and was maintained at 1.7 ± 4.1 and 1.8 ± 2.9 at week 24 and 52, respectively. Ixekizumab response was not affected by clinical variables like body mass index, disease duration or the presence of psoriatic arthritis. However, the bio-naive group showed significantly higher PASI 75 response rate at week 12-16 compared to patients previously exposed to biologic agents (P = 0.037). Twenty-six (26%) patients experienced adverse events (AEs) during the follow-up period, being most of them of mild-to-moderate intensity. The most common AE was local reaction at the site of injection (14/26; 53.8%). At the end of the observational period, 15 (15%) patients discontinued ixekizumab treatment due to limited clinical improvement (n = 11), adverse events (n = 3) or lost to follow-up (n = 1) within a mean ± SD time of 6.0 ± 3.9 months. CONCLUSION The present study illustrates the initial experience with ixekizumab in real-world clinical practice confirming its usefulness and safety in the management of plaque psoriasis patients.
Collapse
Affiliation(s)
- G Deza
- Department of Dermatology, Hospital del Mar-Institut Mar d'Investigacions Mèdiques, Barcelona, Spain
| | - J Notario
- Department of Dermatology, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain
| | - A Lopez-Ferrer
- Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
| | - E Vilarrasa
- Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
| | - M Ferran
- Department of Dermatology, Hospital del Mar-Institut Mar d'Investigacions Mèdiques, Barcelona, Spain
| | - E Del Alcazar
- Department of Dermatology, Hospital Germans Trias i Pujol, Badalona, Spain
| | - J M Carrascosa
- Department of Dermatology, Hospital Germans Trias i Pujol, Badalona, Spain
| | - M Corral
- Department of Dermatology, Hospital Universitari Sagrat Cor, Barcelona, Spain
| | - M Salleras
- Department of Dermatology, Hospital Universitari Sagrat Cor, Barcelona, Spain
| | - M Ribera
- Department of Dermatology, Hospital Parc Taulí, Sabadell, Spain
| | - L Puig
- Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
| | - R M Pujol
- Department of Dermatology, Hospital del Mar-Institut Mar d'Investigacions Mèdiques, Barcelona, Spain
| | - D Vidal
- Department of Dermatology, Hospital Moisès Broggi, Sant Joan Despí, Spain
| | - F Gallardo
- Department of Dermatology, Hospital del Mar-Institut Mar d'Investigacions Mèdiques, Barcelona, Spain
| |
Collapse
|
24
|
Lobato-Berezo A, March-Rodríguez A, Deza G, Bertolín-Colilla M, Pujol RM. Frontal fibrosing alopecia after antiandrogen hormonal therapy in a male patient. J Eur Acad Dermatol Venereol 2018; 32:e291-e292. [PMID: 29377270 DOI: 10.1111/jdv.14825] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Affiliation(s)
- A Lobato-Berezo
- Department of Dermatology, Hospital del Mar-Parc de Salut Mar, Passeig Marítim, 25-29, 08003, Barcelona, Spain.,Department of Dermatology, Hospital Universitari General de Catalunya, Carrer Pedro i Pons 1, 08190, Sant Cugat del Vàlles, Barcelona, Spain
| | - A March-Rodríguez
- Department of Dermatology, Hospital del Mar-Parc de Salut Mar, Passeig Marítim, 25-29, 08003, Barcelona, Spain
| | - G Deza
- Department of Dermatology, Hospital del Mar-Parc de Salut Mar, Passeig Marítim, 25-29, 08003, Barcelona, Spain
| | - M Bertolín-Colilla
- Department of Dermatology, Hospital del Mar-Parc de Salut Mar, Passeig Marítim, 25-29, 08003, Barcelona, Spain
| | - R M Pujol
- Department of Dermatology, Hospital del Mar-Parc de Salut Mar, Passeig Marítim, 25-29, 08003, Barcelona, Spain
| |
Collapse
|
25
|
Fernández-de-Misa R, Hernández-Machín B, Servitje O, Valentí-Medina F, Maroñas-Jiménez L, Ortiz-Romero PL, Sánchez Schmidt J, Pujol RM, Gallardo F, Pau-Charles I, García Muret MP, Pérez Gala S, Román C, Cañueto J, Blanch Rius L, Izu R, Ortiz-Brugués A, Martí RM, Blanes M, Morillo M, Sánchez P, Peñate Y, Bastida J, Pérez Gil A, Lopez-Lerma I, Muniesa C, Estrach T. First-line treatment in lymphomatoid papulosis: a retrospective multicentre study. Clin Exp Dermatol 2017; 43:137-143. [DOI: 10.1111/ced.13256] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/29/2016] [Indexed: 11/30/2022]
Affiliation(s)
- R. Fernández-de-Misa
- Department of Dermatology and Research Unit; Hospital Universitario Nuestra Señora de Candelaria; Santa Cruz de Tenerife Spain
| | - B. Hernández-Machín
- Department of Dermatology; Clínica Buenaderma; Las Palmas de Gran Canaria Spain
| | - O. Servitje
- Department of Dermatology; Hospital Universitari de Bellvitge; IDIBELL; Barcelona Spain
| | - F. Valentí-Medina
- Department of Dermatology; Hospital Universitari de Bellvitge; IDIBELL; Barcelona Spain
| | - L. Maroñas-Jiménez
- Department of Dermatology; Hospital Universitario 12 de Octubre, i+12 Research Institute; Universidad Complutense Madrid; Madrid Spain
| | - P. L. Ortiz-Romero
- Department of Dermatology; Hospital Universitario 12 de Octubre, i+12 Research Institute; Universidad Complutense Madrid; Madrid Spain
| | - J. Sánchez Schmidt
- Department of Dermatology; Hospital del Mar; Universitat Autónoma de Barcelona; Barcelona Spain
| | - R. M. Pujol
- Department of Dermatology; Hospital del Mar; Universitat Autónoma de Barcelona; Barcelona Spain
| | - F. Gallardo
- Department of Dermatology; Hospital del Mar; Universitat Autónoma de Barcelona; Barcelona Spain
| | - I. Pau-Charles
- Department of Dermatology; Hospital Clínico; University of Barcelona; IDIBAPS; Barcelona Spain
| | - M. P. García Muret
- Department of Dermatology; Hospital Santa Creu i Sant Pau; UAB; Barcelona Spain
| | - S. Pérez Gala
- Department of Dermatology; Hospital Universitario Ramón y Cajal; Madrid Spain
| | - C. Román
- Department of Dermatology; Hospital Universitario de Salamanca; Salamanca Spain
| | - J. Cañueto
- Department of Dermatology; Hospital Universitario de Salamanca; Salamanca Spain
| | - L. Blanch Rius
- Department of Dermatology; Hospital de Basurto; Bilbao Spain
| | - R. Izu
- Department of Dermatology; Hospital de Basurto; Bilbao Spain
| | - A. Ortiz-Brugués
- Department of Dermatology; IRBLleida, Hospital Universitari Arnau de Vilanova; Lleida Spain
| | - R. M. Martí
- Department of Dermatology; IRBLleida, Hospital Universitari Arnau de Vilanova; Lleida Spain
| | - M. Blanes
- Department of Dermatology; Hospital General Universitario de Alicante; Alicante Spain
| | - M. Morillo
- Department of Dermatology; Hospital Universitario Virgen del Rocío; Sevilla Spain
| | - P. Sánchez
- Department of Dermatology; Hospital de León; León Spain
| | - Y. Peñate
- Department of Dermatology; Complejo Hospitalario Universitario Insular Materno-Infantil; Gran Canaria, Las Palmas de Gran Canaria Spain
| | - J. Bastida
- Department of Dermatology; Hospital Universitario Dr. Negrín; Las Palmas de Gran Canaria Spain
| | - A. Pérez Gil
- Department of Dermatology; Hospital Virgen de Valme; Sevilla Spain
| | - I. Lopez-Lerma
- Department of Dermatology; Hospital Universitari Vall d'Hebron; Barcelona Spain
| | - C. Muniesa
- Department of Dermatology; Hospital Universitari de Bellvitge; IDIBELL; Barcelona Spain
| | - T. Estrach
- Department of Dermatology; Hospital Clínico; University of Barcelona; IDIBAPS; Barcelona Spain
| |
Collapse
|
26
|
García-Martínez P, Curto-Barredo L, Rovira-López R, Pujol RM. Multiple Epidermolytic Acanthomas on the Scrotum: What Genital Pruritus Can Reveal. Actas Dermosifiliogr (Engl Ed) 2017; 109:81-82. [PMID: 28705521 DOI: 10.1016/j.ad.2017.03.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2016] [Revised: 02/01/2017] [Accepted: 03/18/2017] [Indexed: 11/28/2022] Open
Affiliation(s)
- P García-Martínez
- Servicio Dermatología, Hospital del Mar-Parc de Salut Mar, Barcelona, España.
| | - L Curto-Barredo
- Servicio Dermatología, Hospital del Mar-Parc de Salut Mar, Barcelona, España
| | - R Rovira-López
- Servicio Dermatología, Hospital del Mar-Parc de Salut Mar, Barcelona, España
| | - R M Pujol
- Servicio Dermatología, Hospital del Mar-Parc de Salut Mar, Barcelona, España
| |
Collapse
|
27
|
García-de-la-Fuente MR, Santacana M, Vilardell F, Pujol RM, Gari E, Casanova JM. Vulvar Basal Cell Carcinoma: Four Case Reports With Immunohistochemical Study. J Cutan Med Surg 2017; 21:457-459. [PMID: 28565920 DOI: 10.1177/1203475417712498] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
Abstract
Basal cell carcinomas (BCC) are the most frequent tumours in humans and normally appear in photoexposed areas of the skin. It is widely accepted that BCCs originate at follicular stem cells and consequently are very rare in nonhairy areas. Here, we report 4 cases of vulvar BCC, 3 of which were located in a vulvar semimucous area, a nonphotoexposed area, and a nonhairy area. We have determined the CK7 and CK19 profile of all cases; both are markers of simple epithelium with glandular differentiation. Interestingly, all cases were positively stained for CK7 and CK19. Considering that the vulvar region is rich in sebaceous and apocrine units, we hypothesise a glandular origin of BCCs situated in the vulvar region.
Collapse
Affiliation(s)
- Mª Reyes García-de-la-Fuente
- 1 Department of Dermatology, University Hospital Arnau de Vilanova, Lleida, Spain.,2 Biomedical Research Institute of Lleida (IRBLLEIDA), Lleida, Spain
| | - Maria Santacana
- 2 Biomedical Research Institute of Lleida (IRBLLEIDA), Lleida, Spain.,3 Department of Pathology, University Hospital Arnau de Vilanova, Lleida, Spain
| | - Felip Vilardell
- 3 Department of Pathology, University Hospital Arnau de Vilanova, Lleida, Spain
| | - R M Pujol
- 4 Department of Dermatology, Hospital del Mar. Parc de Salut Mar, Barcelona
| | - Eloi Gari
- 2 Biomedical Research Institute of Lleida (IRBLLEIDA), Lleida, Spain.,5 Department of Basic Medical Sciences, University of Lleida, Lleida, Spain
| | - J M Casanova
- 1 Department of Dermatology, University Hospital Arnau de Vilanova, Lleida, Spain.,2 Biomedical Research Institute of Lleida (IRBLLEIDA), Lleida, Spain.,6 Department of Medicine, University of Lleida, Lleida, Spain
| |
Collapse
|
28
|
Curto-Barredo L, López-Aventín D, Gómez-Martín I, Pujol RM. Recurrent pruritic papules on the elbows as a localized form of polymorphous light eruption. Clin Exp Dermatol 2017; 42:708-710. [PMID: 28543669 DOI: 10.1111/ced.13131] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/27/2016] [Indexed: 11/29/2022]
Affiliation(s)
- L Curto-Barredo
- Department of Dermatology, Hospital del Mar-Parc de Salut Mar, Barcelona, Spain
| | - D López-Aventín
- Department of Dermatology, Hospital del Mar-Parc de Salut Mar, Barcelona, Spain
| | - I Gómez-Martín
- Department of Dermatology, Hospital del Mar-Parc de Salut Mar, Barcelona, Spain
| | - R M Pujol
- Department of Dermatology, Hospital del Mar-Parc de Salut Mar, Barcelona, Spain
| |
Collapse
|
29
|
García-Martínez P, Segura S, Herrero-Gonzalez JE, Pujol RM. Progressive limitation of mouth opening. Actas Dermosifiliogr 2016; 108:278-279. [PMID: 27810101 DOI: 10.1016/j.ad.2016.07.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2016] [Revised: 04/05/2016] [Accepted: 07/27/2016] [Indexed: 10/20/2022] Open
Affiliation(s)
- P García-Martínez
- Departamento de Dermatología, Hospital del Mar, Parc de Salut Mar, Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain.
| | - S Segura
- Departamento de Dermatología, Hospital del Mar, Parc de Salut Mar, Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain
| | - J E Herrero-Gonzalez
- Departamento de Dermatología, Hospital del Mar, Parc de Salut Mar, Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain
| | - R M Pujol
- Departamento de Dermatología, Hospital del Mar, Parc de Salut Mar, Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain
| |
Collapse
|
30
|
García-Martínez P, López Aventín D, Segura S, Gómez-Martín I, Lloreta J, Ibáñez J, Elvira JJ, Pujol RM. In vivo reflectance confocal microscopy characterization of silver deposits in localized cutaneous argyria. Br J Dermatol 2016; 175:1052-1055. [PMID: 26997486 DOI: 10.1111/bjd.14571] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/14/2016] [Indexed: 11/27/2022]
Abstract
Localized cutaneous argyria is a rare condition secondary to skin deposition of silver following exposure to substances containing this metal. The clinical appearance and dermoscopy findings require deep melanocytic lesions and particularly melanoma metastasis to be ruled out. Silver deposits are usually confirmed by scanning electron microscopy and/or energy-dispersive X-ray spectroscopy. Herein we describe the in vivo reflectance confocal microscopy (RCM) features observed in one case of localized cutaneous argyria. These features include the presence of a hyperrefractile network in the papillary dermis and a periadnexal dotted bright pattern. In vivo RCM might be a useful tool for an early diagnosis of this uncommon entity.
Collapse
Affiliation(s)
- P García-Martínez
- Department of Dermatology, Hospital del Mar, Passeig Marítim, 25-29, ES-08003, Barcelona, Spain.
| | - D López Aventín
- Department of Dermatology, Hospital del Mar, Passeig Marítim, 25-29, ES-08003, Barcelona, Spain
| | - S Segura
- Department of Dermatology, Hospital del Mar, Passeig Marítim, 25-29, ES-08003, Barcelona, Spain
| | - I Gómez-Martín
- Department of Dermatology, Hospital del Mar, Passeig Marítim, 25-29, ES-08003, Barcelona, Spain
| | - J Lloreta
- Department of Pathology, Hospital del Mar, Passeig Marítim, 25-29, ES-08003, Barcelona, Spain
| | - J Ibáñez
- Institut de Ciències de la Terra Jaume Almera, CSIC, Barcelona, Spain
| | - J J Elvira
- Institut de Ciències de la Terra Jaume Almera, CSIC, Barcelona, Spain
| | - R M Pujol
- Department of Dermatology, Hospital del Mar, Passeig Marítim, 25-29, ES-08003, Barcelona, Spain
| |
Collapse
|
31
|
Brasileiro A, Martín-Ezquerra G, García-Martinez P, Pujol RM, Giménez-Arnau AM. Allergic reactions to meglumine antimoniate while treating cutaneous leishmaniasis. J Eur Acad Dermatol Venereol 2016; 31:e59-e60. [PMID: 27225343 DOI: 10.1111/jdv.13726] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- A Brasileiro
- Department of Dermatology, Hospital del Mar - Parc de Salut Mar, Barcelona, Spain.,Department of Dermatology, Hospital S. António dos Capuchos, Centro Hospitalar Lisboa Central, Lisbon, Portugal
| | - G Martín-Ezquerra
- Department of Dermatology, Hospital del Mar - Parc de Salut Mar, Barcelona, Spain
| | - P García-Martinez
- Department of Dermatology, Hospital del Mar - Parc de Salut Mar, Barcelona, Spain
| | - R M Pujol
- Department of Dermatology, Hospital del Mar - Parc de Salut Mar, Barcelona, Spain
| | - A M Giménez-Arnau
- Department of Dermatology, Hospital del Mar - Parc de Salut Mar, Barcelona, Spain
| |
Collapse
|
32
|
Deza G, López Aventín D, Salido M, Espinet B, Gilaberte M, Pujol RM. Hyperpigmentation following the Blaschko's lines: a subtle cutaneous manifestation of Turner syndrome with complex mosaicism. Br J Dermatol 2016; 175:1379-1381. [PMID: 27106053 DOI: 10.1111/bjd.14688] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Affiliation(s)
- G Deza
- Department of Dermatology, Department of Pathology, Hospital del Mar - Parc de Salut Mar, Barcelona, Spain
| | - D López Aventín
- Department of Dermatology, Department of Pathology, Hospital del Mar - Parc de Salut Mar, Barcelona, Spain
| | - M Salido
- Department of Molecular Cytogenetics Laboratory, Department of Pathology, Hospital del Mar - Parc de Salut Mar, Barcelona, Spain.,Cancer Research Programme, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
| | - B Espinet
- Department of Molecular Cytogenetics Laboratory, Department of Pathology, Hospital del Mar - Parc de Salut Mar, Barcelona, Spain.,Cancer Research Programme, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
| | - M Gilaberte
- Department of Dermatology, Department of Pathology, Hospital del Mar - Parc de Salut Mar, Barcelona, Spain
| | - R M Pujol
- Department of Dermatology, Department of Pathology, Hospital del Mar - Parc de Salut Mar, Barcelona, Spain
| |
Collapse
|
33
|
García-Díez I, Martínez-Escala ME, Ishii N, Hashimoto T, Mascaró Galy JM, Pujol RM, Herrero-González JE. Usefulness of a Simple Immunohistochemical Staining Technique to Differentiate Anti-p200 Pemphigoid From Other Autoimmune Blistering Diseases: A Report of 2 Cases. Actas Dermosifiliogr 2016; 108:e1-e5. [PMID: 27095685 DOI: 10.1016/j.ad.2015.10.019] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2015] [Revised: 09/17/2015] [Accepted: 10/04/2015] [Indexed: 10/21/2022] Open
Abstract
Anti-p200 pemphigoid is a rare autoimmune subepidermal blistering disease characterized by the presence of circulating immunoglobulin G antibodies directed against laminin gamma-1, a 200-kDa protein located in the lamina lucida of the basement membrane. We review the clinical, histopathological and immunological characteristics of the first 2 cases described in Spain. Anti-p200 pemphigoid shares histopathological and immunopathological findings with epidermolysis bullosa acquisita, the main entity in the differential diagnosis. However, its management follows the same guidelines as those used for bullous pemphigoid. The diagnosis is confirmed by immunoblotting, which is a complex technique available in few centers. We propose the immunohistochemical detection of collagen type IV on the floor of the blister, combined with standard immunofluorescence techniques, as a simple, accessible alternative to differentiate anti-p200 pemphigoid from epidermolysis bullosa acquisita.
Collapse
Affiliation(s)
- I García-Díez
- Departamento de Dermatología, Hospital del Mar, Parc de Salut Mar, Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, España.
| | - M E Martínez-Escala
- Departamento de Dermatología, Hospital del Mar, Parc de Salut Mar, Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, España
| | - N Ishii
- Departamento de Dermatología, Facultad de Medicina de la Universidad de Kurume, Fukuoka, Japón
| | - T Hashimoto
- Departamento de Dermatología, Facultad de Medicina de la Universidad de Kurume, Fukuoka, Japón
| | - J M Mascaró Galy
- Departamento de Dermatología, Hospital Clínic, Barcelona, España
| | - R M Pujol
- Departamento de Dermatología, Hospital del Mar, Parc de Salut Mar, Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, España
| | - J E Herrero-González
- Departamento de Dermatología, Hospital del Mar, Parc de Salut Mar, Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, España
| |
Collapse
|
34
|
Casanova JM, Pujol RM, Ferrándiz C, Betlloch I, Bosch RJ, Fernández V, Martí RM, Requena L, Moreno JC, Alegre V, Vilata JJ, Vilar N, Jaén P, Bielsa I, Querol I, Azón T, Borrego L, Mascaró JM, Alsina M, Díaz RM, Suarez R, García-Bustinduy M, García-Patos V, Estrach T. Core Content for Undergraduate Medical Education in Spain: Recommendations of the Instructors' Group of the Spanish Academy of Dermatology and Venereology (AEDV). Actas Dermosifiliogr 2015; 107:125-32. [PMID: 26691244 DOI: 10.1016/j.ad.2015.09.014] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2014] [Revised: 09/30/2015] [Accepted: 09/30/2015] [Indexed: 11/29/2022] Open
Abstract
BACKGROUND Skin problems are among the most frequent reasons for seeking medical attention in primary care. In recent years, as a result of the process of adapting medical curricula to the requirements of the European Higher Education Area, the amount of time students spend learning the concepts of dermatology has been reduced in many universities. MATERIAL AND METHODS In order to reach a consensus on core content for undergraduate education in dermatology, we sent a survey to the 57 members of the instructors' group of the Spanish Academy of Dermatology and Venereology (AEDV), asking their opinions on what objectives should be set for a dermatology course in Spain. A total of 131 previously selected objectives were listed. We then applied the Delphi method to achieve consensus on which ones the respondents considered important or very important (score≥4 on a Likert scale). RESULTS Nineteen responses (33%) were received. On the second round of the Delphi process, 68 objectives achieved average scores of at least 4. The respondents emphasized that graduates should understand the structure and functions of the skin and know about bacterial, viral, and fungal skin infections, the most common sexually transmitted diseases (STDs), and the 4 main inflammatory dermatoses. Students should also learn about common complaints, such as itching and bald patches; the management of dermatologic emergencies; purpura and erythema nodosum as signs of internal disease; and the prevention of STDs and skin cancer. During clinical clerkships students should acquire the communication skills they will need to interview patients, write up a patient's medical history, and refer the patient to a specialist. CONCLUSIONS The AEDV's group of instructors have defined their recommendations on the core content that medical faculties should adopt for the undergraduate subject of dermatology in Spain.
Collapse
Affiliation(s)
| | - R M Pujol
- Universitat Autònoma de Barcelona, Barcelona, España
| | - C Ferrándiz
- Universitat Autònoma de Barcelona, Barcelona, España
| | - I Betlloch
- Universitad Miguel Hernández, Elche, Alicante, España
| | - R J Bosch
- Universitat de Málaga, Málaga, España
| | - V Fernández
- Universidad de Santiago de Compostela, Santiago de Compostela, España
| | - R M Martí
- Universitat de Lleida, Lleida, España
| | - L Requena
- Universidad Autónoma de Madrid, Madrid, España
| | | | - V Alegre
- Universidad de Valencia, Valencia, España
| | - J J Vilata
- Universidad de Valencia, Valencia, España
| | - N Vilar
- Universitat de Girona, Girona, España
| | - P Jaén
- Universidad de Alcalá de Henares, Madrid, España
| | - I Bielsa
- Universitat Autònoma de Barcelona, Barcelona, España
| | - I Querol
- Universidad de Zaragoza, Zaragoza, España
| | - T Azón
- Universitat Rovira i Virgili, Reus, Tarragona, España
| | - L Borrego
- Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, España
| | | | - M Alsina
- Universitat de Barcelona, Barcelona, España
| | - R M Díaz
- Universidad Alfonso X el Sabio, Madrid, España
| | - R Suarez
- Universidad Complutense de Madrid, Madrid, España
| | | | | | - T Estrach
- Universitat de Barcelona, Barcelona, España
| | | |
Collapse
|
35
|
García-Díez I, Curto-Barredo L, Weller K, Pujol RM, Maurer M, Giménez-Arnau AM. Cross-Cultural Adaptation of the Urticaria Control Test From German to Castilian Spanish. Actas Dermosifiliogr 2015; 106:746-52. [PMID: 26164835 DOI: 10.1016/j.ad.2015.05.009] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2015] [Revised: 05/19/2015] [Accepted: 05/25/2015] [Indexed: 10/23/2022] Open
Abstract
INTRODUCTION The clinical concept of urticaria embraces a heterogeneous group of conditions classified according to their clinical course as acute (lasting less than 6 weeks) or chronic (lasting 6 weeks or more). Chronic urticaria may be either spontaneous or induced. Few tools are available for monitoring the various clinical forms of this disease or for evaluating its impact on quality of life. The recently developed Urticaria Control Test to evaluate disease control is available in German, the original language, and American English. OBJECTIVE To culturally adapt the long and short versions of the Urticaria Control Test to Castilian Spanish to ensure equivalence between the translated items and those of the original version. MATERIAL AND METHODS To translate the Urticaria Control Test we followed the International Society for Pharmacoeconomics and Outcomes Research good practice guidelines, starting with forward translation and moving through back translation and cognitive debriefing steps. RESULTS Three items were modified when the first Spanish version, translated from German, was discussed (cognitive debriefing). The revised translation was then translated back to German and sent to the Urticaria Control Test authors, who modified one item they considered had acquired a different focus through translation. A third Spanish version was then prepared and after minor proofreading changes was considered definitive. CONCLUSIONS This study was the first step in making it possible to use the Urticaria Control Test questionnaire in Castilian Spanish. The next step will be to validate the translated questionnaire.
Collapse
Affiliation(s)
- I García-Díez
- Departamento de Dermatología, Hospital del Mar, Parc de Salut Mar, Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, España.
| | - L Curto-Barredo
- Departamento de Dermatología, Hospital del Mar, Parc de Salut Mar, Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, España
| | - K Weller
- Departamento de Dermatología y Alergia, Allergie-Centrum-Charité, Charité-Universitätsmedizin, Berlín, Alemania
| | - R M Pujol
- Departamento de Dermatología, Hospital del Mar, Parc de Salut Mar, Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, España
| | - M Maurer
- Departamento de Dermatología y Alergia, Allergie-Centrum-Charité, Charité-Universitätsmedizin, Berlín, Alemania
| | - A M Giménez-Arnau
- Departamento de Dermatología, Hospital del Mar, Parc de Salut Mar, Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, España
| |
Collapse
|
36
|
López Aventín D, Gallardo F, Sanchez-Gonzalez B, Pujol RM, Salar A. Metronomic chemotherapy for advanced and refractory cutaneous T-cell lymphoma treatment. J Eur Acad Dermatol Venereol 2014; 30:136-8. [PMID: 25073876 DOI: 10.1111/jdv.12624] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Affiliation(s)
- D López Aventín
- Department of Dermatology, Hospital del Mar - Parc de Salut Mar, Barcelona, Spain
| | - F Gallardo
- Department of Dermatology, Hospital del Mar - Parc de Salut Mar, Barcelona, Spain
| | - B Sanchez-Gonzalez
- Department of Clinical Haematology, Hospital del Mar - Parc de Salut Mar, Barcelona, Spain
| | - R M Pujol
- Department of Dermatology, Hospital del Mar - Parc de Salut Mar, Barcelona, Spain
| | - A Salar
- Department of Clinical Haematology, Hospital del Mar - Parc de Salut Mar, Barcelona, Spain
| |
Collapse
|
37
|
Toll A, Lloveras B, Masferrer E, Ferrándiz-Pulido C, García-Patos V, Gheit T, Pujol RM, Tommasino M. Human beta papillomavirus DNA study in primary cutaneous squamous cell carcinomas and their corresponding metastases. Arch Dermatol Res 2013; 306:93-5. [PMID: 24173126 DOI: 10.1007/s00403-013-1424-8] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2013] [Revised: 10/10/2013] [Accepted: 10/17/2013] [Indexed: 01/08/2023]
Abstract
The association between beta human papillomavirus (HPV) types and cutaneous squamous cell carcinomas (cSCCs) is controversial. Several studies have found such an association, especially at early stages of carcinogenesis, but the presence of beta HPV types in aggressive cSCCs has only been reported in three patients previously. We aimed to search for beta HPV DNA in primary cSCCs and their corresponding lymph node metastases in a series of patients. The presence of DNA from 25 beta HPV types was determined using a multiplex PCR protocol in 35 primary cSCCs from 35 patients and their corresponding lymph node metastases. DNA from beta HPV types was detected in 9 % of primary cSCCs and in 13 % of metastases. No primary cutaneous SCC or lymphatic metastases were found to share the same HPV DNA. These data suggest that beta HPV types do not play an etiopathogenic role in advanced stages of squamous cell carcinogenesis.
Collapse
Affiliation(s)
- A Toll
- Department of Dermatology, Hospital del Mar, Parc de Salut Mar, Pg/Marítim 25-29, 08003, Barcelona, Spain,
| | | | | | | | | | | | | | | |
Collapse
|
38
|
Rozas-Muñoz E, Martínez-Escala ME, Barranco C, Gallardo F, Pujol RM. Asymptomatic acquired yellowish linear bands in the lumbar area. Clin Exp Dermatol 2013; 38:321-3. [PMID: 23517366 DOI: 10.1111/j.1365-2230.2012.04454.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- E Rozas-Muñoz
- Department of Dermatology, Hospital del Mar, Autonomous University of Barcelona, Barcelona, Spain.
| | | | | | | | | |
Collapse
|
39
|
Peñate Y, Hernández-Machín B, Pérez-Méndez LI, Santiago F, Rosales B, Servitje O, Estrach T, Fernández-Guarino M, Calzado L, Acebo E, Gallardo F, Salar A, Izu R, Ortiz-Romero PL, Pujol RM, Fernández-de-Misa R. Intralesional rituximab in the treatment of indolent primary cutaneous B-cell lymphomas: an epidemiological observational multicentre study. The Spanish Working Group on Cutaneous Lymphoma. Br J Dermatol 2012; 167:174-9. [PMID: 22356294 DOI: 10.1111/j.1365-2133.2012.10902.x] [Citation(s) in RCA: 52] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Abstract
BACKGROUND Intravenous rituximab is a safe and effective option for the treatment of systemic non-Hodgkin B-cell lymphoma. The effectiveness of intralesional rituximab (ILR) in primary cutaneous B-cell lymphomas (PCBL) has been described in a small number of patients. OBJECTIVES To evaluate the effectiveness, tolerance and adverse effects of ILR in patients with follicle centre (FCL) and marginal zone (MZL) PCBL. METHODS This was an epidemiological observational multicentre study of patients with PCBL treated with ILR. RESULTS Seventeen patients with MZL and 18 with FCL PCBL were included. The median number of lesions treated was two per patient. The treatment regimen used in 74% of the patients was a course of three injections in a single week at 1-month intervals. The dose per lesion and day of treatment was 10 mg in 71% of the patients. The median cumulative dose of rituximab per lesion was 60 mg (range 13-270) and per patient was 150 mg (range 20-360 mg). Complete response (CR) and partial response were achieved in 71% and 23% of patients, respectively. The median time to CR in patients who received 10 mg of ILR per lesion was 8 weeks. Similar response rates were observed in MZL and FCL. Median disease-free survival was 114·1 weeks. No parameters that significantly predicted CR were identified. Adverse reactions were recorded in 19 patients; the most frequent was localized pain at the injection site. Median follow-up was 21 months. CONCLUSIONS Intralesional rituximab is a well-tolerated and effective treatment for FCL and MZL PCBL. It should be considered a useful alternative in patients with recurrent lesions and in which the sequelae of radiotherapy or surgery would be significant.
Collapse
Affiliation(s)
- Y Peñate
- Department of Dermatology, Complejo Hospitalario Universitario Insular Materno-Infantil, Gran Canaria, Las Palmas de GC, Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
40
|
Rozas-Muñoz E, Lepoittevin JP, Pujol RM, Giménez-Arnau A. Allergic contact dermatitis to plants: understanding the chemistry will help our diagnostic approach. Actas Dermosifiliogr 2012; 103:456-77. [PMID: 22217935 DOI: 10.1016/j.ad.2011.07.017] [Citation(s) in RCA: 33] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2011] [Revised: 07/06/2011] [Accepted: 07/29/2011] [Indexed: 11/29/2022] Open
Abstract
Allergic contact dermatitis due to plants is common. Potentially allergenic plants and plant products are found in many everyday environments, such as the home, the garden, the workplace, and recreational settings. By improving our knowledge of allergenic plant-derived chemical compounds, we will be better positioned to identify novel allergens. We review the most relevant chemical allergens that contribute to plant allergic contact dermatitis and propose a clinical classification system based on 5 major families of chemical sensitizers: α-methylene-γ-butyrolactones, quinones, phenol derivatives, terpenes, and miscellaneous structures (disulfides, isothiocyanates, and polyacetylenic derivates). We also describe the different clinical pictures of plant allergic contact dermatitis and review currently available patch test materials. A better understanding of the specific allergens involved in plant allergic contact dermatitis will help to predict cross-reactivity between different plant species or families.
Collapse
Affiliation(s)
- E Rozas-Muñoz
- Department of Dermatology, Hospital del Mar. Parc de Salut Mar, Barcelona, Spain.
| | | | | | | |
Collapse
|
41
|
Ferran M, Calvet J, Almirall M, Pujol RM, Maymó J. Alopecia areata as another immune-mediated disease developed in patients treated with tumour necrosis factor-α blocker agents: Report of five cases and review of the literature. J Eur Acad Dermatol Venereol 2011; 25:479-84. [PMID: 20586836 DOI: 10.1111/j.1468-3083.2010.03770.x] [Citation(s) in RCA: 54] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
BACKGROUND Tumour necrosis factor antagonists (anti-TNF-α) have demonstrated the efficacy in different chronic immune inflammatory disorders. Within the spectrum of adverse events, autoimmune diseases have been observed, including cases of alopecia areata (AA). OBJECTIVES The objective of the study is to characterize AA developed during anti-TNF-α therapy. METHODS We present five new cases and review all the cases reported in the literature (eleven). RESULTS One third of the cases had a positive (personal or family) history of AA. Most of them presented with rapid extensive AA, usually involving the ophiasis area. Prognosis was usually poor, with slight response to treatments. In the cases where anti-TNF-α therapy was maintained, the course did not seem to change. CONCLUSIONS Although rare, AA developed during anti-TNF-α therapy might be more frequent than suggested by reports of isolated cases. Personal and family history of autoimmune disease might alert clinicians to their possible development or relapse once the anti-TNF-α therapy is started.
Collapse
Affiliation(s)
- M Ferran
- Departments of Dermatology Rheumatology, Hospital del Mar, IMAS, Barcelona, Spain.
| | | | | | | | | |
Collapse
|
42
|
Casanova JM, Soria X, Borrego L, De Argila D, Ribera M, Pujol RM. [Portfolios: a tool for the training and assessment of residents in dermatology, part 2]. Actas Dermosifiliogr 2011; 102:325-35. [PMID: 21531360 DOI: 10.1016/j.ad.2010.12.005] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2010] [Revised: 12/12/2010] [Accepted: 12/16/2010] [Indexed: 11/25/2022] Open
Abstract
A portfolio is a collection of material documenting reflection about practice. It contains documents (eg, case histories and questionnaires the resident has used), images, and video recordings that reveal that an individual has acquired the competencies needed for professional practice. This assessment tool simultaneously supports learning and provides evidence for certifying competence. The adoption of portfolio use by a dermatology department requires the support of both the training supervisor and the chief of department. The learning objectives defined by the National Board for Medical-Surgical Dermatology and Venereology must be taken into consideration so that ways to assess each objective can be included; this approach supports holistic ongoing education as well as the certification of competencies the resident finally achieves. Use of portfolios in medical residency training can improve on current assessment methods, which we believe lack precision. We propose that portfolios gradually begin to replace the resident's training log. We are currently developing an online software application that will facilitate the use of portfolios.
Collapse
Affiliation(s)
- J M Casanova
- Servicio de Dermatología, Hospital Universitari Arnau de Vilanova, Lleida, España.
| | | | | | | | | | | |
Collapse
|
43
|
Masferrer E, Martin-Ezquerra G, Martínez-Escala E, Pujol RM, Giménez-Arnau A. Eosinophilic panniculitis triggered by intramuscular penicillin and occupational setting. Allergy 2011; 66:436-7. [PMID: 21284653 DOI: 10.1111/j.1398-9995.2010.02490.x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- E Masferrer
- Department of Dermatology, Hospital del Mar Passeig, Barcelona, Spain.
| | | | | | | | | |
Collapse
|
44
|
Ferran M, Gallardo F, Coromines JM, Pujol RM. Nodular lesion on the sole of the foot in a patient after a trip to Venezuela. Clin Exp Dermatol 2010; 35:453-4. [PMID: 20518922 DOI: 10.1111/j.1365-2230.2009.03303.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- M Ferran
- Department of Dermatology, Hospital del Mar, IMAS, Barcelona, Spain.
| | | | | | | |
Collapse
|
45
|
Ferran M, Ferran M, Galván AB, Giménez-Arnau A, Giménez-Arnau A, Pujol RM, Pujol RM, Santamaría-Babi LF, Santamaría-Babi LF. [Production of interleukin-8 by circulating CLA+ T cells with skin tropism in patients with psoriasis and in healthy controls]. Actas Dermosifiliogr 2010; 101:151-155. [PMID: 20223157] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/28/2023] Open
Abstract
BACKGROUND Psoriasis is an immune-mediated disease typically associated with cutaneous neutrophilic infiltration and Munro microabscesses. Interleukin (IL)-8 is one of the main neutrophil-attracting chemokines. Although keratinocytes have traditionally been considered to be the principal source of IL-8 in psoriasis, we present data that suggest that cutaneous lymphocyte associated antigen (CLA) + T lymphocytes synthesize this cytokine. MATERIAL AND METHODS Six patients with psoriasis and 6 healthy controls were studied. Immunomagnetic separation was used to isolate CLA+ and CLA- T lymphocytes and IL-8 and interferon (IFN)-gamma production was quantified for each cell subpopulation using enzyme-linked immunosorbent assay. Finally, gene expression of IL-8 was analyzed by reverse transcriptase-polymerase chain reaction. RESULTS CLA+ and CLA- T lymphocytes from patients with psoriasis and from controls showed a significantly increased production of IFN-gamma when activated, whereas only activated CLA+ T lymphocytes (from patients and controls) synthesized IL-8. The higher level of expression of IL-8 and IFN-gamma by CLA+T lymphocytes in comparison to CLA- cells was confirmed. DISCUSSION Previous studies have confirmed IL-8 production by T lymphocytes in inflammatory skin diseases with neutrophil-rich infiltrates, such as acute generalized exanthematous pustulosis, Behçet disease, and pustular psoriasis. We have confirmed the role of the subset of T lymphocytes with skin tropism (CLA+) in IL-8 production in nonpustular psoriasis.
Collapse
Affiliation(s)
- M Ferran
- Servicio de Dermatología, Hospital del Mar-IMIM, Barcelona, Spain.
| | | | | | | | | | | | | | | | | |
Collapse
|
46
|
de-Misa RF, García M, Dorta S, Febles C, Hernández-Machín B, Serrano S, Pujol RM, Suárez J. Solitary oral ulceration as the first appearance of lymphomatoid papulosis: a diagnostic challenge. Clin Exp Dermatol 2010; 35:165-8. [DOI: 10.1111/j.1365-2230.2009.03251.x] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
47
|
|
48
|
Ferran M, Bussaglia E, Matias-Guiu X, Pujol RM. Bilateral and symmetrical palmoplantar punctate keratoses in childhood: a possible clinical clue for an early diagnosis ofPTENhamartoma-tumour syndrome. Clin Exp Dermatol 2009; 34:e28-30. [DOI: 10.1111/j.1365-2230.2008.03136.x] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
49
|
Martín-Ezquerra G, Fisa R, Riera C, Rocamora V, Fernández-Casado A, Barranco C, Serra T, Baró T, Pujol RM. Role of Leishmania spp. infestation in nondiagnostic cutaneous granulomatous lesions: report of a series of patients from a Western Mediterranean area. Br J Dermatol 2009; 161:320-5. [PMID: 19500101 DOI: 10.1111/j.1365-2133.2009.09282.x] [Citation(s) in RCA: 38] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
BACKGROUND Leishmaniasis is a parasitic disease prevalent in countries of the Mediterranean area. OBJECTIVES The potential role of Leishmania as the aetiological factor for cutaneous granulomatous lesions in a series of patients from a Western Mediterranean area was evaluated. The practical usefulness of Leishmania-specific polymerase chain reaction (PCR) amplification and immunohistochemical techniques in skin biopsy specimens was assessed. METHODS Twenty-five skin biopsies diagnosed as nonspecific granulomatous dermatoses were included in the study. A panel of histopathological features was blindly evaluated by two independent observers. Only those cases showing nondiagnostic clinicopathological features and lacking demonstrable microorganisms after bacteriological, mycological or mycobacteriological cultures and specific stains (Ziehl-Neelsen, Giemsa, Gram, periodic acid-Schiff stains) were finally selected. Quantitative real-time PCR was performed in all selected samples. In available samples, immunohistochemical detection of specific Leishmania spp. antigens was also performed. RESULTS From the selected 25 biopsies, Leishmania spp. DNA was detected by real-time PCR in 13 cases. In seven of eight PCR-positive cases the presence of a varying density of amastigotes could also be demonstrated immunohistochemically. CONCLUSIONS Leishmania infection seems to be an important aetiological factor in cutaneous granulomatous lesions showing nondiagnostic features in endemic areas. In such areas, Leishmania-specific PCR amplification and/or immunohistochemical studies may be useful diagnostic tools. These techniques may be specifically indicated in the evaluation of patients showing nonspecific granulomatous inflammatory infiltrates of unknown aetiology lacking the histopathological evidence of parasites.
Collapse
|
50
|
Gallardo F, García-Muret MP, Servitje O, Estrach T, Bielsa I, Salar A, Abella E, Barranco C, Pujol RM. Cutaneous lymphomas showing prominent granulomatous component: clinicopathological features in a series of 16 cases. J Eur Acad Dermatol Venereol 2009; 23:639-47. [DOI: 10.1111/j.1468-3083.2008.03020.x] [Citation(s) in RCA: 46] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|